Health Condition 1: null- Adenotonsillar hypertrophy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Children of the age range 3-10 years; both genders. 2 Individuals with radiological evidence of adenoidal hypertrophy (assessed on digital lateral cephalometric radiography). 3 Signs and symptoms of obstructive sleep apnoea (OSA) such as obstructive breathing during sleep, mouth breathing, snoring. 4Enlarged tonsils/adenoids. 5 Informed consent of parents/guardians who are willing to participate their children in the study and informed assent of children of age 7 and above who are willing to participate in the study. Verbal assent from the children under the age of 7 years.
Exclusion criteria
Exclusion criteria: 1Severely inflamed tonsils with high fever (more than 104 F) during screening. 2Known cranio-facial anomalies such as cleft lip, cleft palate. 3Previous tonsil, adenoid, or pharyngeal surgery. 4 Known life threatening disease/systemic illness (tuberculosis, cancer, AIDS) during screening. 5 Neuromuscular disorders, cognitive deficits or mental retardation. 6 Severe OSA requiring urgent surgery as per the engaged ENT consultant if any
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1Changes in symptoms , related to ATH such as mouth breathing, snoring, Obstructive breathing during sleep at the end of 6th months of treatment. 2 Radiological changes in ATH at the end of 6 months of treatment Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Assessment of quality of sleep at the end of 6 months of treatment. 2To identify useful medicines for adenotonsillar hypertrophy. Timepoint: 6 months | — |
Countries
India
Contacts
Central Council for Research in Homoeopathy